Project Details
Description
A single-arm, open-label study to evaluate the safety and tolerability of infusing HSC835 in patients with hematological malignancies undergoing UCB transplantation using a non-myeloablative conditioning regimen
| Status | Finished |
|---|---|
| Effective start/end date | 7/21/13 → 1/31/17 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.